Black Friday Tomorrow: buy 2, get a 3rd free on every product Buy 2 = get a 3rd free, on every product Tomorrow: 3rd one free Buy 2 = 3rd one free Starts inEnds in Shop now
Free shipping on orders from 160 €from 160 € · 3-vial Retatrutide 30 mg pack at 150 € See the packs
MyPeptide Blog
Shop Quality Certificates Blog Contact About
Order
MyPeptide
Shop Quality Certificates Blog Contact About
ORDER
MyPeptide Blog
Home Shop Quality Blog Contact My account
Order
Skip to content
MyPeptide Logo - European Research Peptide Shop
  • Home
  • Shop
  • Quality
  • Blog
  • Contact
  • About
  • My account
MyPeptide Logo - European Research Peptide Shop
  • About — MyPeptide Research Team
  • Buy KPV in Luxembourg: price, COA Janoshik and delivery | MyPeptide.eu
  • Buy KPV in Belgium: price, COA Janoshik and delivery | MyPeptide.eu
  • Buy KPV in France: price, COA Janoshik and delivery | MyPeptide.eu
  • Buy retatrutide in Belgium: R3 Reta 10 mg at €59.90 | MyPeptide.eu
  • Buy GHK-Cu in Luxembourg: price, COA Janoshik and delivery | MyPeptide.eu
  • Buy GHK-Cu in Belgium: price, COA Janoshik and delivery | MyPeptide.eu
  • Buy GHK-Cu in France: price, COA Janoshik and delivery | MyPeptide.eu
  • Buy Research Peptides in Europe | MyPeptide.eu
  • Acquistare GHK-Cu in Italia: prezzo, COA Janoshik e consegna | MyPeptide.eu
  • Acquistare KPV in Italia: price, COA Janoshik and instructions | MyPeptide.eu
  • AHK-Cu hair: what studies say, AHK-Cu or GHK-Cu, price | MyPeptide.eu
  • Anti-Aging Peptides Europe — GHK-Cu, BPC-157 & More
  • Blog
  • Buy GHK-Cu in Ireland: Price, Janoshik COA and Delivery | MyPeptide.eu
  • Buy GHK-Cu in Malta: Price, Janoshik COA and Delivery | MyPeptide.eu
  • Buy KPV in Ireland: Price, Janoshik COA and Delivery | MyPeptide.eu
  • Buy KPV in Malta: Price, Janoshik COA and Delivery | MyPeptide.eu
  • Buy Peptides in Ireland: Supplier Guide, COA and Delivery | MyPeptide.eu
  • Buy Research Peptides in Europe
  • Buy Retatrutide in Ireland: Price, COA and Supplier | MyPeptide.eu
  • Buy Retatrutide in Malta: Price, COA and Supplier | MyPeptide.eu
  • Cagrilintide: what is it, mechanism, tests and status
  • Cagrilintide: side effects and safety
  • CagriSema: Trial results, tirzepatide and the FDA
  • Peptide calculator: reconstitution (mg/ml) and half-life | MyPeptide.eu
  • Certificates of analysis
  • COA of tesamorelin: Janoshik 98.2% analysis and verification | MyPeptide.eu
  • Cagrilintide COA: Janoshik report 99.836%
  • GHK-Cu COA: 3 Janoshik analyses, recognizing genuine GHK-Cu | MyPeptide.eu
  • KLOW COA: 4 peptides measured by Janoshik
  • KPV COA: Janoshik report 98.8%
  • MOTS-c COA: Janoshik 99.553% analysis and verification | MyPeptide.eu
  • COA retatrutide: 7 verifiable Janoshik certificates of analysis | MyPeptide.eu
  • How to verify a Janoshik Certificate of Analysis (COA) in 5 steps
  • Comprar Cagrilintide em Portugal
  • Comprar GHK-Cu en España: precio, COA Janoshik y envío | MyPeptide.eu
  • Buy KPV in Portugal: preço, COA Janoshik and purchase | MyPeptide.eu
  • Buy KPV in Spain: price, COA of Janoshik and envío | MyPeptide.eu
  • Buy Retatrutide in Portugal: preço desde 5 €/mg, COA Janoshik | MyPeptide.eu
  • Comprar Retatrutide en España: precio desde 5 €/mg, COA Janoshik | MyPeptide.eu
  • Comprar Tirzepatide em Portugal
  • Terms of Use
  • General Terms and Conditions of Sale – MyPeptide
  • Contact details – Legal notice
  • Cumpără GHK-Cu în România: preț, COA Janoshik și livrare | MyPeptide.eu
  • Cumpără KPV în România: preț, COA Janoshik și livrare | MyPeptide.eu
  • Cumpără Retatrutide în România: preț, COA și furnizor | MyPeptide.eu
  • Bacteriostatic water: uses, pharmacy, price and storage | MyPeptide.eu
  • FAQ – Frequently Asked Questions about Research Peptides
  • GHK-Cu: A Complete Guide to Copper Peptide (Research, Forms, Prices) | MyPeptide.eu
  • GHK-Cu hair: what studies say, GHK-Cu or AHK-Cu | MyPeptide.eu
  • Injectable or cream-based GHK-Cu: What forms, what are the differences? | MyPeptide.eu
  • GHK-Cu kaufen in Deutschland: Preis, Janoshik-COA & Versand | MyPeptide.eu
  • GHK-Cu kaufen in Österreich: Preis, Janoshik-COA und Zustellung | MyPeptide.eu
  • GHK-Cu kopen in Nederland: prijs, Janoshik-COA en levering | MyPeptide.eu
  • GHK-Cu kupić w Polsce: cena, certyfikat Janoshik i dostawa | MyPeptide.eu
  • GHK-Cu vásárlás Magyarországon: ár, Janoshik COA és szállítás | MyPeptide.eu
  • GLP-3: What is it? Retatrutide, a triple agonist (price, COA) | MyPeptide.eu
  • Complete Guide to NAD+: Longevity, Sirtuins, and DNA Repair
  • Complete Guide to Retatrutide: Mechanisms, Research and Clinical Results
  • Home
  • Kjøp GHK-Cu i Norge: pris, Janoshik-COA og levering | MyPeptide.eu
  • Kjøp retatrutide i Norge: pris, COA og leverandør | MyPeptide.eu
  • Kjøpe KPV i Norge: taken, Janoshik-COA and levering | MyPeptide.eu
  • KLOW: Side effects, risks and reviews
  • KLOW benefits: what studies really say
  • KLOW peptide: what is it, composition, studies and price
  • KLOW vs GLOW vs Wolverine: what are the differences?
  • Køb GHK-Cu i Danmark: pris, Janoshik-COA og levering | MyPeptide.eu
  • Køb retatrutide i Danmark: pris, COA og leverandør | MyPeptide.eu
  • Købe KPV i Danmark: taken, Janoshik-COA and levering | MyPeptide.eu
  • Köp GHK-Cu i Sverige: pris, Janoshik-COA och leverans | MyPeptide.eu
  • Köp retatrutide i Sverige: pris, COA och leverantör | MyPeptide.eu
  • Köpa KPV i Sverige: taken, Janoshik-COA och leverans | MyPeptide.eu
  • Koupit GHK-Cu v Česku: cena, COA Janoshik a doručení | MyPeptide.eu
  • Koupit KPV v Česku: cena, COA Janoshik a doručení | MyPeptide.eu
  • Koupit retatrutide v Česku: cena, COA a dodavatel | MyPeptide.eu
  • KPV: studied benefits for the gut and skin
  • KPV: What is it, how does it work, research, and its status?
  • KPV: Side effects, safety and status
  • KPV can be found in Germany: Prices, Janoshik-COA and Versand | MyPeptide.eu
  • KPV can be found in Österreich: Prices, Janoshik-COA and Delivery | MyPeptide.eu
  • KPV open in Nederland: prices, Janoshik-COA in leverage | MyPeptide.eu
  • Oral or injectable KPV: what the studies say
  • KPV or BPC-157: what are the differences?
  • KPV vásárlás Magyarországon: ár, Janoshik COA és szállítás | MyPeptide.eu
  • Kupić KPV w Polsce: cena, COA Janoshik i dostawa | MyPeptide.eu
  • Kúpiť GHK-Cu na Slovensku: cena, COA Janoshik a doručenie | MyPeptide.eu
  • Kúpiť KPV na Slovensku: cena, COA Janoshik a dručenie | MyPeptide.eu
  • Kúpiť retatrutide na Slovensku: cena, COA a dodávateľ | MyPeptide.eu
  • Kupiti GHK-Cu u Hrvatskoj: cijena, Janoshik COA i dostava | MyPeptide.eu
  • Kupiti KPV u Hrvatskoj: cijena, Janoshik COA i dostava | MyPeptide.eu
  • Kupiti Retatrutide u Hrvatskoj: cijena, COA i dobavljač | MyPeptide.eu
  • Mistä ostaa KPV:tä Suomessa? Hinta, Janoshik-COA ja toimitus | MyPeptide.eu
  • MOTS-c: What is it, effects, studies and price (complete guide) | MyPeptide.eu
  • MOTS-c: Side effects, dangers, and reviews (what we know) | MyPeptide.eu
  • MOTS-c and weight loss: metabolism, insulin, what the studies say | MyPeptide.eu
  • MOTS-c and sport: the peptide that "mimics exercise," what the research says | MyPeptide.eu
  • MOTS-c vs SS-31 (elamipretide): Two mitochondrial peptides compared | MyPeptide.eu
  • MyPeptide reviews: is it a legit site?
  • Wave to buy GHK-Cu in Portugal: preço, COA Janoshik and entrega | MyPeptide.eu
  • Osta GHK-Cu Suomesta: hinta, Janoshik-COA ja toimitus | MyPeptide.eu
  • Osta retatrutide Suomesta: hinta, COA ja toimittaja | MyPeptide.eu
  • Copper peptides: GHK-Cu, AHK-Cu, differences and uses | MyPeptide.eu
  • Pharmaceutical Grade Peptides Europe — HPLC 99%+
  • R3 shot, injection, or pen: the different forms of retatrutide | MyPeptide.eu
  • Pirkt GHK-Cu Latvijā: cena, Janoshik COA un piegāde | MyPeptide.eu
  • Pirkt KPV Latvijā: cena, Janoshik COA un piegāde | MyPeptide.eu
  • Pirkt Retatrutide Latvijā: cena, COA un piegādātājs | MyPeptide.eu
  • Pirkti GHK-Cu Lietuvoje: kaina, Janoshik COA ir pristatymas | MyPeptide.eu
  • Pirkti KPV Lietuvoje: kaina, Janoshik COA ir pristatymas | MyPeptide.eu
  • Pirkti Retatrutide Lietuvoje: kaina, COA ir tiekėjas | MyPeptide.eu
  • Shipping Policy
  • Privacy Policy – MyPeptide
  • Return and refund policy
  • GHK-Cu price in Europe: 13 sellers compared
  • Price of retatrutide (R3) in France: from €5/mg
  • R3 (retatrutide): Is it a medication? Pharmacy, prescription, tablet | MyPeptide.eu
  • Research Peptides Fast Shipping Europe — 2–5 Days
  • Retatrutide: legal status in Europe, country by country (2026)
  • Retatrutide France: supplier, prices from €5/mg, COA Janoshik | MyPeptide.eu
  • Retatrutide kaufen in Deutschland: Preis ab 5 €/mg, Janoshik-COA | MyPeptide.eu
  • Retatrutide kaufen in Österreich: Preis, COA und Anbieter | MyPeptide.eu
  • Retatrutide kopen in Nederland en België: prices, COA & leverage | MyPeptide.eu
  • Retatrutide kupić w Polsce: cena, COA i dostawca | MyPeptide.eu
  • Retatrutide Luxembourg: Price, Purchase & Reliable Supplier | MyPeptide.eu
  • Retatrutide prezzo e acquisto in Italia: da 5 €/mg, COA Janoshik | MyPeptide.eu
  • Retatrutide vásárlás Magyarországon: ár, COA és beszállító | MyPeptide.eu
  • Retatrutide vs. cagrilintide: Differences, mechanisms, and trials | MyPeptide.eu
  • Retatrutide vs tesamorelin: differences, targets, and studies | MyPeptide.eu
  • Tesamorelin: What is it, studies, status and price | MyPeptide.eu
  • Tesamorelin: Side effects, dangers, and reviews (clinical trials) | MyPeptide.eu
  • Tesamorelin and visceral (belly) fat: what the trials show | MyPeptide.eu
  • Tesamorelin and bodybuilding: what the research really says | MyPeptide.eu
  • Weight Loss Peptides Europe — Retatrutide & More
  • Αγορά GHK-Cu στην Ελλάδα: Τιμή, COA Janoshik και Παράδοση | MyPeptide.eu
  • Αγορά GHK-Cu στην Κύπρο: Τιμή, COA Janoshik και Παράδοση | MyPeptide.eu
  • Αγορά KPV στην Ελλάδα: Τιμή, COA Janoshik και Παράδοση | MyPeptide.eu
  • Αγορά KPV στην Κύπρο: Τιμή, COA Janoshik και Παράδοση | MyPeptide.eu
  • Αγορά Retatrutide στην Ελλάδα: Τιμή, COA και Προμηθευτής | MyPeptide.eu
  • Αγορά Retatrutide στην Κύπρο: Τιμή, COA και Προμηθευτής | MyPeptide.eu
  • Buy Research Peptides — Retatrutide, GHK-Cu, NAD+ | MyPeptide.eu
  • Cart
  • Quality
  • Checkout
  • Contact
  • My account
By Samayyy / May 15, 2026
Weight loss
16-minute read

R3 Weight loss: what is R3 (retatrutide)?

The "R3" everyone's talking about for weight loss is retatrutide. Retatrutide (LY3437943) is the first triple GLP-1/GIP/glucagon agonist to enter a phase 3 clinical trial. With a reduction in body weight of up to 24% in phase 2 studies, it surpasses in efficacy all molecules known to date in obesity research.

-24%
Body weight (Ph.2)
R3
3 receptors (GLP-1/GIP/GCG)
Ph.3
Test in progress
~6 days
Elimination half-life

What is R3 for weight loss?

R3 is the nickname for retatrutide (code LY3437943), a molecule developed by Eli Lilly. "R3" refers to its three receptors: GLP-1, GIP, and glucagon. It is also known as "Reta," "the R," “ GLP-3 ” or even “ratatouille” on TikTok and Instagram, where people talk about “R3 for slimming” or “R3 weight loss”.

  • This is not an authorized medication Retatrutide is still in phase 3 clinical trials. It does not have marketing authorization in France or Europe, and it is not sold in pharmacies.
  • It is not available in tablet form. In clinical trials, it is administered by weekly injection. What is circulating in Europe is a lyophilized powder in a vial, sold as a research peptide.
  • Why is it being talked about so much? : this is the molecule that has achieved the highest average weight loss ever published for this type of treatment, ahead of semaglutide and tirzepatide (detailed figures below).

R3 peptide at MyPeptide: R3 peptide 10 mg (lyophilized retatrutide powder, intended exclusively for scientific research) is €59.90, with verifiable Janoshik analysis reports. All formats, from 10 to 60 mg, are available on our retatrutide purchase page.

What is Retatrutide?

Retatrutide (INN name, development code LY3437943) is a molecule developed by Eli Lilly that belongs to the new class of multi-receptor incretin agonists. Unlike Semaglutide (a mono-GLP-1 agonist) or Tirzepatide (a dual GLP-1/GIP agonist), Retatrutide simultaneously activates three distinct receptors:

  • GLP-1 Receptor (Glucagon-Like Peptide-1) — regulation of appetite, slowing of gastric emptying, stimulation of insulin
  • GIP Receptor (Glucose-Dependent Insulinotropic Polypeptide) — potentiation of the insulinotropic effect, reduction of postprandial glucagon levels
  • Glucagon receptor — increased energy expenditure, increased hepatic lipolysis, reduced de novo lipogenesis

It is this simultaneous triple action that fundamentally distinguishes Retatrutide and explains its superior effectiveness on fat mass compared to previous generations of GLP-1 peptides.

🔬 Molecular structure

Retatrutide is a 39-amino-acid peptide conjugated to a C18 fatty acid chain via a spacer, giving it a prolonged half-life of approximately 6 days (allowing for weekly administration in a clinical protocol). Its molecular mass is approximately 4,720 Da.

Mechanism of action: how Retatrutide affects weight

Action on the GLP-1 receptor — appetite control

Activation of the GLP-1 receptor (GLP-1R) in the hypothalamus and the nucleus of the solitary tract induces a reduction in food intake via several pathways:

  • Reduction of circulating ghrelin (the hunger hormone)
  • Increased satiety signals (peptide YY, CCK)
  • Slowing of gastric emptying (increased feeling of prolonged satiety)
  • Activation of POMC/CART neurons and inhibition of NPY/AgRP neurons in the hypothalamus

Action on the GIP receptor — metabolic potentiation

GIP (formerly known as "gastric inhibitory hormone") plays a complex role in lipid and glucose metabolism. Activation of the GIP receptor (GIPR) by Retatrutide:

  • Potentiates the glucose-dependent insulinotropic effect (insulin sensitizer)
  • Reduces insulin resistance in adipose tissue
  • Modulates lipogenesis in adipocytes
  • Improves bone metabolism (effect observed in research)

Action on the glucagon receptor — the differentiating novelty

This is where Retatrutide differs radically from Tirzepatide. Activation of the glucagon receptor (GCGR):

  • Increases basal energy expenditure (hepatic thermogenesis and adipose tissue)
  • Stimulates hepatic lipolysis — mobilization of fats stored in the liver (NAFLD/NASH)
  • Reduces de novo lipogenesis in the liver
  • Promotes mild ketogenesis, preferential use of fatty acids as an energy substrate

This glucagon component explains why Retatrutide shows a particularly marked reduction in liver fat in studies, in addition to overall fat mass loss.

Results of clinical trials

Phase 2 — Results published (NEJM 2023)

The phase 2 multicenter, randomized, double-blind, placebo-controlled study, published in the New England Journal of Medicine in 2023, included 338 adults with obesity (BMI ≥ 30) over a period of 48 weeks.

Dose tested Average weight loss at 48 weeks % of participants ≥ 15% loss % of participants ≥ 20% loss
Placebo -2,1% 1% 0%
Retatrutide 1 mg -8,7% 18% 6%
Retatrutide 4 mg -17,1% 53% 32%
Retatrutide 8 mg -22,8% 73% 50%
Retatrutide 12 mg -24.2% 83% 62%
ℹ️ Putting things into perspective

For comparison, Semaglutide 2.4 mg (Wegovy) achieved -15% in 68 weeks in the STEP-1 study, and Tirzepatide 15 mg (Mounjaro) achieved -22.5% in 72 weeks in the SURMOUNT-1 study. Retatrutide 12 mg achieved -24.2% in only 48 weeks.

Side effects observed in phase 2

The adverse effect profile is consistent with the class of GLP-1 agonists:

  • Nausea: 40-60% (dose-dependent, usually transient during the titration phase)
  • Vomiting: 15-30%
  • Diarrhea : 20-35%
  • Constipation : 15-25%
  • Mild tachycardia: observed with high doses (glucagon component)
  • Discontinuation due to adverse effects: ~7% of participants (12 mg dose)

Phase 3 — ongoing (TRIUMPH-1, TRIUMPH-2, TRIUMPH-3)

Eli Lilly launched the TRIUMPH program in 2024 for phase 3 studies of Retatrutide in obesity, with three major trials:

  • TRIUMPH-1: obesity without comorbidity (n ≈ 2000, 72 weeks)
  • TRIUMPH-2: obesity + type 2 diabetes (n ≈ 1500)
  • TRIUMPH-3: obesity + high cardiovascular risk (MACE)

Retatrutide vs Semaglutide vs Tirzepatide — Comparative Table

Criteria Semaglutide Tirzepatide Retatrutide
Mechanism GLP-1 monoagonist GLP-1 + GIP GLP-1 + GIP + GCG
Maximum weight loss (trials) ~15% (68 weeks) ~22.5% (72 weeks) ~24.2% (48 weeks)
Liver fat reduction Moderate High Very high
Basal energy expenditure Slightly modified Slightly modified Augmented (GCG)
Stage of development Marketed Marketed Phase 3
Research availability Available Available Available
Half-life ~7 days ~5 days ~6 days

The role of the glucagon receptor in fat loss

The glucagonergic component is the key element that differentiates Retatrutide and justifies the particular scientific interest in this molecule in research protocols on body composition.

Historically, researchers feared that activating the glucagon receptor would induce problematic hyperglycemia. Eli Lilly resolved this tension by balancing the relative activities: strong GLP-1/GIP activation sufficiently stimulates insulin secretion to counteract the hyperglycemic effect of glucagon, while preserving the metabolic benefits (thermogenesis, lipolysis) of GCGR activation.

🔬 Body composition research

Phase 2 data show that Retatrutide preferentially reduces visceral fat mass (the most metabolically harmful adipose tissue) and liver adipose tissue, while preserving lean mass more effectively compared to Semaglutide alone. Follow-up studies with DEXA are ongoing in the TRIUMPH program.

Retatrutide and NASH/NAFLD: an additional benefit

Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are major comorbidities of obesity. Phase 2 data show an 82% reduction in liver fat content with Retatrutide 12 mg versus a 0.3% increase with placebo after 24 weeks, as measured by MRI-PDFF (Sanyal et al., Nature Medicine 2024).

Eli Lilly is also conducting specific trials of Retatrutide in NASH, where the glucagon component (direct hepatic lipolysis) represents a specific mechanistic advantage.

Applications in preclinical research

In a laboratory research setting, Retatrutide is being studied for:

  • Experimental modeling of obesity and its metabolic comorbidities
  • The study of incretin signaling pathways (GLP-1R, GIPR, GCGR) and their synergistic interactions
  • Research on the gut microbiota and its interaction with GLP-1 agonists
  • Investigating the neuroendocrine effects on food reward circuits
  • Models of hepatic steatosis and metabolic inflammation
Read also
  • Semaglutide vs Retatrutide vs Tirzepatide: a scientific comparison of GLP-1 peptides
  • A Complete Guide to Peptides for Weight Loss in Experimental Research
  • How the GLP-1 receptor works: molecular mechanisms and research implications

Order Retatrutide for your research

MyPeptide offers research-grade Retatrutide, HPLC certified 99%+, with a Janoshik COA available before purchase. Discreet shipping within 2 to 5 business days from the European Union.

Buy R3 peptide 10 mg (retatrutide) →

Frequently Asked Questions about the R3

Is R3 a medicine?

No. R3 (retatrutide) is not yet an authorized medicine: Eli Lilly is conducting phase 3 trials (TRIUMPH program) and no application for authorization has been submitted in Europe to date. Therefore, R3 is not available in pharmacies, nor can it be prescribed. The country-by-country status is detailed on our page about the legal status of retatrutide in Europe, and the questions about pharmacies, prescriptions, and tablets on the page about whether R3 is a medicine.

How much weight does the R3 lose in testing?

In the phase 2 trial published in the New England Journal of Medicine (2023), the average weight loss reached 24.2% at 48 weeks at a weekly dose of 12 mg, compared to 2.1% with placebo. These are averages from medically supervised clinical trials, not a promise of individual results.

Is R3 available in tablet form?

No. Retatrutide is not available in tablet or capsule form; trials use it as a weekly injection. A product sold as "R3 tablets" is not retatrutide.

What is the difference between R3, semaglutide and tirzepatide?

Semaglutide activates one receptor (GLP-1), tirzepatide two (GLP-1 and GIP), and R3 three (GLP-1, GIP, and glucagon). The glucagon receptor increases energy expenditure, which explains the greater weight loss observed in the trials.

Where can I find R3 and at what price?

R3 is only available as a research peptide from online vendors. Prices range from €5 to €12.50 per mg depending on the vendor: see our R3 price comparison in France and our criteria for choosing a retatrutide supplier. At MyPeptide, R3 peptide 10 mg is €59.90, with verifiable Janoshik reports.

Key points to remember

  • Retatrutide is a triple GLP-1/GIP/glucagon agonist — the first molecule of its class in phase 3
  • Average weight loss of -24.2% over 48 weeks at a dose of 12 mg (phase 2)
  • The glucagon component increases basal energy expenditure and hepatic lipolysis — a mechanism absent in Semaglutide and Tirzepatide
  • Tolerability profile similar to GLP-1 class (nausea mainly during the titration phase)
  • Of particular interest for NAFLD/NASH research due to the combined hepatoprotective effect
  • Phase 3 (TRIUMPH program) underway since 2024
Warning : This article is provided for scientific informational purposes only. Retatrutide is a research compound not approved as a medicine. The data presented are from published clinical trials and do not constitute medical advice. All MyPeptide.eu products are intended exclusively for scientific laboratory research.

Scientific sources: Jastreboff et al., NEJM 2023 — Retatrutide Phase 2 · NCT04881760 — Phase 2 Clinical Trial

📦 Buy Retatrutide in Europe

Available at MyPeptide.eu · Delivery France, Germany, Italy, Spain · COA HPLC 99%+

Scientific sources

  1. Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial — Jastreboff AM et al. (2023)
  2. Retatrutide Shows Multiple Metabolic Benefits in Diet-Induced Obese MASH Mouse and Hamster Models — Briand F et al. (2026)
  3. The Triple-Agonist Revolution: Retatrutide and the Paradigm Shift in Multi-Hormonal Pharmacotherapy for Obesity and Cardiometabolic Comorbidities — Ganamurali N et al. (2026)
  4. Retatrutide Phase 3 — Weight Loss Maintenance (TRIUMPH-6) — ClinicalTrials.gov (2025)
Recommended product
Retatrutide R3 10mg — Triple Agonist GLP-1/GIP/Glucagon
Janoshik certified 99%+ HPLC purity. Freeze-dried, COA per batch.
View product — €59.90

To compare with other GLP-1 molecules, see our Retatrutide vs Tirzepatide vs Semaglutide comparison.

Previous

Glossary of research peptides: essential terms from A to Z

Following

KLOW: The Tissue Repair Peptide Blend (GHK-Cu · BPC-157 · TB-500 · KPV) — Scientific Guide

Leave a comment Cancel reply

Your email address will not be published. Required fields are indicated with an asterisk (*). *

Warning : The products offered on MyPeptide.eu are intended exclusively for scientific research in the laboratory.

© 2026 MyPeptide.eu — All rights reserved · Designed in Europe · GDPR compliant
Certificates of AnalysisIs MyPeptide legit?Terms & ConditionsPrivacy PolicyTerms of ServiceReturn & Refund PolicyShipping PolicyLegal Notice
100% secure paymentVisaApple PayGoogle Pay
FRENDEITESPTNLPLSV
Back to top